Physician profile
Ernest White
NPI 1295748283
$3,202.05
in general payments reported to CMS, 2019-2025
37 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $451 · 2021: $510 · 2022: $356 · 2023: $326 · 2024: $777 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $993.16 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $255.01 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $196.49 | 2019-2025 | Verquvo, Belsomra, Pifeltro |
| Janssen Pharmaceuticals, INC | $190.84 | 2019-2024 | Xarelto, Spravato |
| Amgen INC. | $170.98 | 2019-2024 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $153.26 | 2019-2025 | Jardiance, Amyvid, Kisunla |
| Abbvie INC. | $122.89 | 2021-2024 | Ubrelvy, Mavyret |
| Mylan Specialty L.P. | $112.13 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.76 | 2021-2025 | Jardiance |
| Allergan, INC. | $87.77 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $69.38 | 2019-2024 | Airsupra |
| Philips North America LLC | $66.82 | 2021-2024 | (Ak6) Vest Therapy |
| Gilead Sciences, INC. | $58.55 | 2025 | Epclusa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.29 | 2020-2024 | Xifaxan |
| Dexcom, INC. | $50.31 | 2024 | Dexcom G6 Transmitter |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.